Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasm

Thromb Res. 2015 Oct;136(4):839-40. doi: 10.1016/j.thromres.2015.07.026. Epub 2015 Jul 29.

Authors

Emmanuelle Verger¹, Isabelle Crassard², Bruno Cassinat³, Sylvia Bellucci⁴

Affiliations

¹ AP-HP, Service de Biologie Cellulaire, Hôpital Saint-Louis, Paris, France.
² AP-HP, Service de Neurologie, Hôpital Lariboisière, Paris, France.
³ AP-HP, Service de Biologie Cellulaire, Hôpital Saint-Louis, Paris, France. Electronic address: bruno.cassinat@aphp.fr.
⁴ AP-HP, Service d'Hématologie Biologique, Hôpital Lariboisière, Paris, France.

PMID: 26281713
DOI: 10.1016/j.thromres.2015.07.026

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Calreticulin / genetics*
Chronic Disease
Female
Humans
Incidence
Male
Middle Aged
Mutation*
Myeloproliferative Disorders / genetics*
Venous Thrombosis / genetics*
Young Adult

Substances

CALR protein, human
Calreticulin